Home

INDV

Indivior Pharmaceuticals, Inc.

NASDAQHealthcareDrug Manufacturers - Specialty & Generic

$39.50

-0.25%

2026-05-08

About Indivior Pharmaceuticals, Inc.

Indivior Pharmaceuticals, Inc., together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and related disorders in the United States, Europe, Canada, Australia, and internationally. It develops medicines to treat substance use disorders. The company's core marketed products include SUBLOCADE buprenorphine extended-release monthly injections; and SUBOXONE Film, a buprenorphine and naloxone sublingual film. It also manufactures SUBOXONE Tablet, a buprenorphine and naloxone sublingual tablet; and SUBUTEX Tablet, a buprenorphine sublingual tablet for the treatment of opioid use disorder (OUD). In addition, the company is developing INDV-2000, a selective orexin-1 receptor antagonist that is in Phase 2 clinical trial for the treatment of moderate to severe OUD; and INDV-6001, a buprenorphine-based long-acting injectable for the treatment of OUD in collaboration with Alar Pharmaceuticals Inc. The company was formerly known as Indivior PLC. and changed its name to Indivior Pharmaceuticals, Inc. in January 2026. Indivior Pharmaceuticals, Inc. was incorporated in 2014 and is headquartered in North Chesterfield, Virginia.

Key Fundamentals

P/E Ratio

20.24

Forward P/E

10.07

EPS (TTM)

$1.95

Revenue Growth (YoY)

19.2%

Profit Margin

19.5%

Beta

1.20

Market Cap

$4.67B

Avg Volume (10D)

3.1M

Recent Breakout Signals

Near-Breakout WatchD1
2026-04-30
Momentum BreakoutD1
2026-04-30
Momentum BreakoutD1
2026-02-25
Near-Breakout WatchD1
2026-02-23
Momentum BreakoutD1
2025-11-21
Near-Breakout WatchD1
2025-11-20
Near-Breakout WatchD1
2025-11-03

Recent Price Range (60 Days)

60D High

$41.00

60D Low

$27.68

Avg Volume

2.5M

Latest Close

$39.50

Get breakout alerts for INDV

Sign up for Breakout Scanner to receive daily notifications when INDV triggers breakout signals. Build custom AI screeners and backtest strategies.

Start Free Trial

7-day free trial. No card required.

Indivior Pharmaceuticals, Inc. (INDV) is listed on the NASDAQ (NASDAQ). Breakout Scanner monitors INDV daily for breakout patterns including long-term ceiling breakouts, momentum breakouts, and near-breakout watch setups. INDV operates in the Healthcare sector within the Drug Manufacturers - Specialty & Generic industry. Data is provided for informational purposes only and does not constitute financial advice.